StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO) stock

BIONYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO.B
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3060% above fair value
$358.19−2.07 (-0.57%)

Close on Nov 17, 2026Market cap $9.74BP/E 44.1Yield –

Bio-Rad Laboratories price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Bio-Rad Laboratories's price to book ratio was 1.4× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.9× to 1.7×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.4×+0.2
2025Dec 31, 20251.2×−0.0
2024Dec 31, 20241.2×+0.1
2023Dec 29, 20231.1×−0.4
2022Dec 30, 20221.5×−0.0
2021Dec 31, 20211.5×−0.5
2020Dec 31, 20202.0×−0.2
2019Dec 31, 20192.2×+0.7
2018Dec 31, 20181.4×−1.1
2017Dec 29, 20172.5×+0.5
2016Dec 30, 20162.0×+0.3
2015Dec 31, 20151.7×+0.1
2014Dec 31, 20141.6×−0.1
2013Dec 31, 20131.7×+0.1
2012Dec 31, 20121.6×−0.1
2011Dec 30, 20111.6×−0.4
2010Dec 31, 20102.0×–

More Bio-Rad Laboratories figures

See a number that looks wrong?